ATE234622T1 - Nicht-immunogene blutplättchen und rote blutzellen enthaltende zubereitungen - Google Patents

Nicht-immunogene blutplättchen und rote blutzellen enthaltende zubereitungen

Info

Publication number
ATE234622T1
ATE234622T1 AT96943630T AT96943630T ATE234622T1 AT E234622 T1 ATE234622 T1 AT E234622T1 AT 96943630 T AT96943630 T AT 96943630T AT 96943630 T AT96943630 T AT 96943630T AT E234622 T1 ATE234622 T1 AT E234622T1
Authority
AT
Austria
Prior art keywords
immunogenic
blood cells
red blood
plates
containing non
Prior art date
Application number
AT96943630T
Other languages
English (en)
Inventor
Sherrill J Slichter
Original Assignee
Puget Sound Blood Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Puget Sound Blood Ct filed Critical Puget Sound Blood Ct
Application granted granted Critical
Publication of ATE234622T1 publication Critical patent/ATE234622T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Transplantation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT96943630T 1995-12-04 1996-12-04 Nicht-immunogene blutplättchen und rote blutzellen enthaltende zubereitungen ATE234622T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56684795A 1995-12-04 1995-12-04
PCT/US1996/019467 WO1997020570A1 (en) 1995-12-04 1996-12-04 Non-immunogenic and toleragenic platelet and red blood cell compositions

Publications (1)

Publication Number Publication Date
ATE234622T1 true ATE234622T1 (de) 2003-04-15

Family

ID=24264638

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96943630T ATE234622T1 (de) 1995-12-04 1996-12-04 Nicht-immunogene blutplättchen und rote blutzellen enthaltende zubereitungen

Country Status (7)

Country Link
EP (1) EP0874635B1 (de)
JP (1) JP2000503631A (de)
AT (1) ATE234622T1 (de)
AU (1) AU725669B2 (de)
CA (1) CA2239574A1 (de)
DE (1) DE69626853T2 (de)
WO (1) WO1997020570A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1902740A1 (de) * 2006-09-19 2008-03-26 Maco Pharma S.A. Blutbeutelsystem und Verfahren, um Pathogene in Blutplättchenkonzentraten mit Hilfe des Blutbeutelsystems zu neutralisieren
WO2013059343A1 (en) 2011-10-17 2013-04-25 Massachusetts Institute Of Technology Intracellular delivery
US10124336B2 (en) 2013-08-16 2018-11-13 Massachusetts Institute Of Technology Selective delivery of material to cells
CN122564053A (zh) 2014-10-31 2026-08-14 麻省理工学院 递送生物分子至免疫细胞
WO2016077761A1 (en) 2014-11-14 2016-05-19 Massachusetts Institute Of Technology Disruption and field enabled delivery of compounds and compositions into cells
US20170369845A1 (en) * 2014-12-31 2017-12-28 Anthrogenesis Corporation Methods for isolation of platelets
AU2016206870B2 (en) 2015-01-12 2022-02-17 Massachusetts Institute Of Technology Gene editing through microfluidic delivery
JP6925984B2 (ja) 2015-07-09 2021-08-25 マサチューセッツ インスティテュート オブ テクノロジー 無核細胞への物質の送達
US11613759B2 (en) 2015-09-04 2023-03-28 Sqz Biotechnologies Company Intracellular delivery of biomolecules to cells comprising a cell wall

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5714524A (en) * 1980-07-02 1982-01-25 Asahi Chem Ind Co Ltd Preparation of dispersion of platelet
JPS5762222A (en) * 1980-10-03 1982-04-15 Asahi Chem Ind Co Ltd Preparation of concentrated solution of platelet, its device and part
DE3650139T2 (de) * 1985-07-05 1995-03-09 Hutchinson Fred Cancer Res Verfahren zum reduzieren der immunogenizität und zum induzieren immunologischer toleranz.
AU578554B2 (en) * 1986-01-24 1988-10-27 Japanese Red Cross Society Centrifugal method of separating blood components
DE69032500T2 (de) * 1989-09-12 1998-11-26 Pall Corp Verfahren und vorrichtung zur behandlung von blut für die menschliche transfusion
DE4129516C2 (de) * 1991-09-06 2000-03-09 Fresenius Ag Verfahren und Vorrichtung zum Trennen von Blut in seine Bestandteile

Also Published As

Publication number Publication date
EP0874635A1 (de) 1998-11-04
AU725669B2 (en) 2000-10-19
JP2000503631A (ja) 2000-03-28
CA2239574A1 (en) 1997-06-12
DE69626853T2 (de) 2004-02-19
WO1997020570A1 (en) 1997-06-12
AU1282597A (en) 1997-06-27
DE69626853D1 (de) 2003-04-24
EP0874635B1 (de) 2003-03-19

Similar Documents

Publication Publication Date Title
TR199802421T2 (xx) Doku yenilenmesini d�zenleyen maddeler.
TR200101867T2 (tr) CCR5 modülatörleri olarak piperidinler
EE03253B1 (et) (R)-5-karbamoüül-8-fluoro-3-N,N-diasendatud-amino-3,4-dihüdro-2H-1-bensopüraani d, nende valmistamise protsess ja neid sisaldavad ravimkoostised
TR200101793T2 (tr) CCR5 modülatörleri olarak azabisikloalkanlar
ATE270557T1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
ATE216590T1 (de) Arzneimittelformulierungen für il-12
NO20003698D0 (no) Orale sammensetninger
ATE106740T1 (de) Herstellung von t-zellen und t-zellmembranen, verwendbar zur verhütung und behandlung von autoimmunkrankheiten.
TR200100366T2 (tr) Aktif madde dağıtmaya mahsus bileşikler ve bileşimler.
NO962791L (no) Preparater inneholdende nukleinsyrer, deres fremstilling og anvendelse
ES2147720T3 (es) Factor de celulas madre.
IT8422580A0 (it) Composizioni che le contengono e proteine di membrana cellulare, procedimento per prepararle.
BR8802492A (pt) Composicao esterilizante e de alto grau desinfetante,inodora
ATE214610T1 (de) Neuartige pharmazeutische verwendungen von krill- enzymen
DE69626853D1 (de) Nicht-immunogene Blutplättchen und rote Blutzellen enthaltende Zubereitungen
AU6745287A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
PT80752B (pt) Processo de preparacao de composicoes farmaceuticas solidas contendo di-hidropiridinas
DE69528170D1 (de) Intrazelluläre verabreichung therapeutischer sustanzenmittels virosomen
EP0689586B8 (de) Funktion und aktivität des viralen proteins r (vpr)
GB9825096D0 (en) Cells,culture methods and their uses
DE69534633D1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
DE69835828D1 (de) Muc-1 derivate und deren verwendung zur behandlung von krebsassoziierter muc-1 mucin induzierter immunosuppression
DK161384C (da) Pyrazolooe3,4,5-klaaacridinforbindelser og farmaceutiske praeparater indeholdende saadanne forbindelser
EP0261648A3 (en) Cell membrane proteins, compositions containing them and procedure for their preparation
FI960839A0 (fi) Uusia tripeptidejä, jotka ovat käyttökelpoisia immuuni- ja CNS-terapiassa

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties